← Leaderboards
Richard Thomas Coughlin
Immucell Corporation
$4,285,506
Attributed
$6,716,858
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $989.3K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,716,858 · 5
By mechanism
R44$6,029,528 · 2
R43$687,330 · 3
Top collaborators
- Stephen L Carrithers6 shared
- Stephen Carrithers1 shared
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisPhysiciansAmericanHigh RiskPerformanceDiagnostic TestsUnited States National Institutes Of HealthSpecificityBiological MarkersCommercializationEarly TreatmentPrototypeClinical TrialsBaseAffectResearch Clinical TestingCohortEarly DiagnosisCardiovascular Risk FactorDiagnosticEventAlbuminsChronic Kidney FailureCharacteristics
Grant awards (11)
A PROGNOSTIC ASSAY FOR METASTATIC CLEAR CELL RENAL CELL CARCINOMA$538,827
R44 · FY2025 · CA · contact PI
A PROGNOSTIC ASSAY FOR METASTATIC CLEAR CELL RENAL CELL CARCINOMA$927,997
R44 · FY2024 · CA · contact PI
DIAGNOSTIC TEST FOR METASTATIC KIDNEY CANCER$300,000
R43 · FY2018 · CA
NOVEL ASSAY TO DETECT CHRONIC KIDNEY DISEASE$933,270
R44 · FY2017 · DK
NOVEL ASSAY TO DETECT CHRONIC KIDNEY DISEASE$965,044
R44 · FY2016 · DK
NOVEL ASSAY TO DETECT CHRONIC KIDNEY DISEASE$989,285
R44 · FY2015 · DK
BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE$183,839
R44 · FY2014 · DK
BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE$535,755
R44 · FY2013 · DK
BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE$955,511
R44 · FY2012 · DK
Jenseniin P and Nisin to treat topical infections$191,083
R43 · FY2002 · GM
NOVEL ANTIMICROBIAL TREATMENT FOR MASTITIS$196,247
R43 · FY2001 · GM